Bristol-Myers Squibb buy klostergang
Start price
08.09.17
/
50%
€56.59
Target price
08.03.18
€67.65
Performance (%)
6.63%
End price
08.03.18
€59.63
Summary
This prediction ended on 08.03.18 with a price of €59.63. The BUY prediction by klostergang finished with a performance of 6.63%. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bristol-Myers Squibb | 1.231% | 1.231% | -16.763% | -33.543% |
| iShares Core DAX® | 0.650% | 3.212% | 21.634% | 71.886% |
| iShares Nasdaq 100 | 1.650% | 0.322% | 5.422% | 113.046% |
| iShares Nikkei 225® | 1.232% | 1.549% | 15.333% | 47.267% |
| iShares S&P 500 | 1.413% | 0.282% | 3.125% | 68.687% |
Comments by klostergang for this prediction
In the thread Bristol-Myers Squibb diskutieren
klostergang stimmt der Buy-Einschätzung von Joe130978 zu
klostergang stimmt am 08.09.2017 der Buy-Einschätzung von Joe130978 mit dem Kursziel 75$ zu.
Überschrift: Bristol-Myers Squipp = Bad news kaufen!!
https://seekingalpha.com/news/3294374-bristol-myers-opdivo-outperforms-docetaxel-treatment-resistant-lung-cancer-patients-late
(Laufzeit überschritten)
Stopped prediction by klostergang for Bristol-Myers Squibb
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€41.38
04.01.19
04.01.19
€81.18
04.11.21
04.11.21
33.28%
17.06.21
17.06.21
Bristol-Myers Squibb
Start price
Target price
Perf. (%)
€64.20
15.03.15
15.03.15
€68.00
15.09.15
15.09.15
-17.70%
15.09.15
15.09.15